Login / Signup

Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last?

Aygul Tantik Pakİsmet ÜstünYildizhan Şengül
Published in: Arquivos de neuro-psiquiatria (2021)
In our study, there was a significant reduction in analgesic intake and headache days in the first and second months after BoNTA injection, and an increase was observed in the third month.
Keyphrases
  • botulinum toxin
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • neuropathic pain
  • anti inflammatory
  • weight gain